FDA Relaxes Safety Requirements For Alzheimer's Trials, But Uncertainty Persists

Sponsors and contract research organizations expressed cautious optimism about FDA's adoption of some of the recommendations of the Alzheimer's Association Research Roundtable Workgroup, but the agency isn't specifying which recommendations it is accepting.